APRINOIA Therapeutics Company

APRINOIA Therapeutics specializes in the diagnotics and therapeutics for Alzheimer's disease and tauopathies.

Founded Date: 2015
Last Funding Type: Grant
Headquarters: Taipei, T'ai-pei, Taiwan
Investors Number: 5
Technology: Anti-infective Drugs
Employee Number: 11-50
Industry: PharmTech
Estimated Revenue: $1M to $10M
Last Funding Date: 2019-05-23
Funding Status: Early Stage Venture
Investor Type: For Profit
Total Funding: 17530000